Please login to the form below

CRPC

This page shows the latest CRPC news and features for those working in and with pharma, biotech and healthcare.

CRPC, and a 52% prostate-specific antigen (PSA) response.

Exelixis bounces back with new prostate cancer data

The COSMIC-021 trial evaluated the combination treatment in patients with locally advanced or metastatic castration-resistant prostate cancer (CRPC), whose disease had progressed on prior novel hormone therapy. ... Exelixis intends to file the
Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

First approval could give Clovis an opportunity to build familiarity with its brand among clinicians treating CRPC before its big pharma rivals reach the market, although its rivals are hot on ... the first half of 2020, while GSK/J&J have also reported
Pfizer raises forecast following growth of biopharma business

For Pfizer, the potential approval in this indication could help drive Xtandi's growth even further – the drug picked up an approval in castration-resistant prostate cancer (CRPC) with non-metastatic ... CRPC last year.
J&J puts pressure on rivals with new Erleada okay in prostate cancer

Meanwhile, Zytiga – which is only approved for metastatic CRPC – pulled in $3.5bn last year, but the start of generic competition in late 2018 was evident in a 21% slump in
Trial backs role for Lynparza in second-line prostate cancer

subpopulation of HRRms – namely BRCA1/BRCA2 and ATM mutations – and that makes PROfound “the only positive phase 3 trial of any PARP inhibitor” in CRPC. ... AZ is also conducting a phase 3 trial (PROPEL) of Lynparza in combination with Zytiga as

More from news
Approximately 1 fully matching, plus 42 partially matching documents found.

Drug launches to watch in 2019

In patients with non-metastatic CRPC, there is a high unmet need to delay development of metastases and the progression to advanced prostate cancer. ... for approval in the US and EU for non-metastatic CRPC on the strength of MFS data from the PROSPER

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Medical Writer, Women’s health, Medical Communications agency, h...: Highly competitive salary

Add my company

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Breaking the silence: It’s time to talk about the menopause: Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips: Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:: Senior Analytics Specialist joins Research Partnership...

Email:
Password: